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Abstract
Background: Esophageal cancer ranks eighth in order of cancer occurrence. Its lethality primarily
stems from inability to detect the disease during the early organ-confined stage and the lack of
effective therapies for advanced-stage disease. Moreover, the understanding of molecular
processes involved in esophageal cancer is not complete, hampering the development of efficient
diagnostics and therapy. Efforts made by the scientific community to improve the survival rate of
esophageal cancer have resulted in a wealth of scattered information that is difficult to find and not
easily amendable to data-mining. To reduce this gap and to complement available cancer related
bioinformatic resources, we have developed a comprehensive database (Dragon Database of
Genes Implicated in Esophageal Cancer) with esophageal cancer related information, as an
integrated knowledge database aimed at representing a gateway to esophageal cancer related data.
Description: Manually curated 529 genes differentially expressed in EC are contained in the
database. We extracted and analyzed the promoter regions of these genes and complemented
gene-related information with transcription factors that potentially control them. We further,
precompiled text-mined and data-mined reports about each of these genes to allow for easy
exploration of information about associations of EC-implicated genes with other human genes and
proteins, metabolites and enzymes, toxins, chemicals with pharmacological effects, disease
concepts and human anatomy. The resulting database, DDEC, has a useful feature to display
potential associations that are rarely reported and thus difficult to identify. Moreover, DDEC
enables inspection of potentially new 'association hypotheses' generated based on the precompiled
reports.
Conclusion: We hope that this resource will serve as a useful complement to the existing public
resources and as a good starting point for researchers and physicians interested in EC genetics.
DDEC is freely accessible to academic and non-profit users at http://apps.sanbi.ac.za/ddec/. DDEC
will be updated twice a year.
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Background
The major histological form of esophageal cancer (EC),
esophageal squamous cell carcinoma (ESCC), comprises
90% of ECs worldwide [1,2]. The poor prognosis of EC
results in a five year survival rate of 5–20% [3]. The
lethality of EC stems from our inability to detect the dis-
ease during the early stage, combined with the lack of
effective therapies for advanced-stage disease. Like most
diseases, EC arises as a consequence of errors occurring in
the cellular regulatory system or errors being introduced
into the genome as mutations causing cellular behavior to
deviate from the norm [4]. Identifying the mechanisms by
which the genomic information is controlled in EC will
provide further insights into partially understood cellular
and molecular functioning that characterizes this disease.
Gene expression in EC is a multifunctional process influ-
enced by chromatin remodeling and the interplay
between transcription regulatory proteins and DNA
sequences known as transcription factor binding sites
(TFBSs) [5,6]. This combination of transcription regula-
tory proteins, TFBSs, and affected transcripts, defines the
transcription regulatory networks (TRNs) that are respon-
sible for the regulation of every transcript encoded in the
genome. Knowledge of these transcripts and the control
mechanisms of their initiation set the stage for inferring
transcriptional regulatory networks and may help in
search for the therapeutic mechanisms to potentially cor-
rect or compensate for the errors underlying pathological
states of EC.
Efforts made by the scientific community to improve the
survival rate associated with EC have resulted in a wealth
of scattered research data. Researchers need to sieve
through this scattered research data to identify relevant
research findings. However, this phase hampers the
research process as the compiling of the relevant informa-
tion is tedious and time consuming. In an attempt to
enhance research endeavors related to EC we have devel-
oped Dragon Database of Genes Implicated in Esophageal
Cancer (DDEC) as an integrated knowledge database that
contains information about various genes differentially
expressed in EC. It should be noted that there are two ini-
tiatives aimed at coordinating activities in producing
resources related to cancer research, such as the Interna-
tional Cancer Genome Consortium – ICGC http://
www.icgc.org/ and caBIG (cancer Biomedical Informatics
Grid™, http://cabig.cancer.gov/. These two intend to pro-
mote specific data formats and other conditions that will
enable easier integration of cancer-related resources.
There are cancer related databases that include informa-
tion on EC, such as Cancer Gene Expression Database
(CGED) [7], PDQ [8] and Oncomine [9]. CGED houses a
collection of gene expression and clinical data from a large
number of patients with major cancers including EC.
CGED expression data have been obtained by adaptor-
tagged competitive PCR (ATAC-PCR) and allows research-
ers to explore the correlation between gene expression and
clinical data for future diagnostic application [7]. PDQ is
the National Cancer Institute's (NCI's) cancer database
that includes peer-reviewed summaries on cancer treat-
ment, screening, prevention, genetics, and complemen-
tary and alternative medicine [8]. The Oncomine
initiative collects and analyzes all published cancer micro-
array data and currently house EC-related microarray data
[9]. However, none of the current public databases
focuses on genes implicated in EC and their potential
associations with other relevant biological, biochemical
and medical entities. Moreover, DDEC provides a combi-
nation of features for exploration of information related
to EC-implicated genes that cannot be found elsewhere,
such as filtering for putative transcription factors shared
amongst promoters of EC-implicated genes, inference of
association networks and precompiled reports that pro-
vide insights into other human genes and proteins,
metabolites and enzymes, toxins, chemicals with pharma-
cological effects, disease concepts and human anatomy
associated with differentially expressed EC-implicated
genes. It also enables finding rare information that will be
likely missed in the common literature search. As a special
feature, DDEC provides a module for generation of 'asso-
ciation hypotheses' between concepts related to EC-impli-
cated genes. Batch queries and database dump are also
provided. We thus believe that DDEC represents a useful
complement to the existing databases and will contribute
to more efficient EC-related research. DDEC is freely
accessible for academic and non-profit users at http://
apps.sanbi.ac.za/ddec/. The semi-automated methodol-
ogy used to populate DDEC genes and related data will be
used to update the database twice a year.
Construction and content
The DDEC is based on the three-tier (layer) (data, logic
and presentation) architecture (Figure 1). The presenta-
tion layer is web-based and implemented in DHTML and
Javascript. The logic layer was implemented as a number
of server side PHP and Perl modules interfaced with the
data layer. Data layer is MySQL, and for the text-mining
purposes, file system based. The relational database
design strictly distinguishes between tables that contain
data entities and tables that establish logical connections
between these data entities. The central data entity is the
gene, to which most other data entities are linked. Other
important data entities are transcription related such as
transcription start sites (TSSs) and transcription factors
(TFs). This is reflected in the entry points that a user can
chose between on the top level of the web-interface.
Information in the DDEC is structured into four distinct
parts:BMC Cancer 2009, 9:219 http://www.biomedcentral.com/1471-2407/9/219
Page 3 of 7
(page number not for citation purposes)
(I) Platform that can be used to search the integrated
gene information through standardized vocabularies.
(II) Selection of the genes of interest from the list. This
search criteria provides users with gene details such as;
general information, gene in other resources, experi-
mental evidence, related proteins, associated path-
ways, associated diseases, orthologous genes,
regulations and text-mined reports that can support
building interactive association networks.
(III) Transcription regulation information which
includes all putative TFBSs for the EC-implicated
genes in DDEC. This segment is useful for gene regula-
tion studies since TFBSs of interest can be selected and
the results will list each TFBS and gene promoter with
corresponding TFBSs. Genes sharing all the selected
TFBSs are listed as well.
(IV) Batch queries and data download interface is pro-
vided to increase utility for users.
DDEC contains information on EC-implicated genes
compiled based on scientific publications from PubMed.
The PubMed database was queried with keyword expres-
sion: "esophageal (cancer OR cancers OR tumor OR
tumors OR carcino* OR adenocarc* OR malign* OR neo-
plasm*)" on 31/01/2008 and 35,892 PubMed abstracts
were retrieved. The search for relevant publications was
further refined using the licensed Dragon Exploration Sys-
tem (DES) from OrionCell http://www.orioncell.org, that
has an integrated Biomedical Text-Miner tool. DES
retrieved a list of 1677 putative genes associated with EC
from the extracted abstracts. Biologists then evaluated
information about experimental conditions these genes
have been subjected to using full-text articles whenever
possible, and abstracts in other cases. When the available
information was insufficient to deduce the correct experi-
mental conditions, the gene has been discarded. Taking
into account that experimental conditions influence gene
expression, DDEC provide details of the cell line, tissue or
cell type, expression status, disease stage, tumor grade,
esophageal cancer type and laboratory method reported
in literature.
A final list of 529 genes was identified in this way and
used to populate the database. The general information
about the genes, which include HGNC ID, approved sym-
bol, approved name, entrez ID, previous symbol, previous
name, aliases, OMIM-related information, and chromo-
some location, were extracted from sources such as
HUGO [10]http://www.genenames.org/ and GeneCards
[11]http://www.genecards.org/index.shtml. Included in
the database are gene related identifiers such as EMBL
[12]http://www.ebi.ac.uk/embl/, Ensembl [13]http://




prot/, Swiss-Prot [18]http://www.expasy.ch/sprot/ and
PDB [19]http://www.rcsb.org/pdb/home/home.do. ID
conversion tools like IDconvertor [20]http://idcon
verter.bioinfo.cnio.es/ and Onto-tools [21]http://vor
tex.cs.wayne.edu/ontoexpress/servlet/UserInfo were used
to convert between different types of identifiers. A sum-
mary of the statistics of the above mentioned features are
listed in documentation. We have provided links to the
relevant sources of data such as gene ontologies [22]http:/
/www.geneontology.org/, Evoc [23]http://www.evocon
The schematic representation of the DDEC structure Figure 1
The schematic representation of the DDEC struc-
ture. The DDEC is based on the three-tier (layer) architec-
ture, namely; data, logic, and presentation.
BMC Cancer 2009, 9:219 http://www.biomedcentral.com/1471-2407/9/219
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tology.org/, and Reactome pathway data [24]http://
www.reactome.org/.
As a useful feature, we generated lists of putative TFBSs
that map to the promoter regions of EC-implicated genes
allowing users to identify genes that share common
TFBSs. For this purpose, promoter sequences were
extracted using mainly FANTOM3 CAGE tag data [25], as
well as TOUCAN v. 3.0.2 [26]. To map TFBSs to promot-
ers we used the TRANSFAC Professional database v.11.4
[27]. All TRANSFAC mammalian matrix models of bind-
ing sites [28]were mapped using the Match™ program
with minFP profiles for optimized thresholds of the matrix
models [29]. The complete list of 529 genes was used to
extract promoter sequences for the identification of puta-
tive TFBSs. Promoter sequences of 409 genes (1200 bp
upstream and 200 bp downstream from the transcription
start site, TSS) were extracted from the Fantom3 CAGE tag
data that correspond to 1582 transcription start sites
(TSSs) that each has at least five tags in the tag cluster and
a minimum of three tags in the representative tag [25]. An
additional 108 promoter sequences (1200 bp upstream
and 200 bp downstream from the TSS) were extracted
using Toucan v. 3.0.2 [26].
As an additional feature, for each of the 529 EC-impli-
cated genes, we extracted all related PubMed documents
and analyzed them using DES. DES uses a dictionary
based text-mining approach to extract information used
for the precompiled reports by mapping the entities from
the dictionaries to the submitted PubMed documents. We
applied six manually curated DES dictionaries namely;
human genes and proteins, metabolites and enzymes, tox-
ins, chemicals with pharmacological effects, disease con-
cepts and human anatomy. These dictionaries were
compiled from literature and public databases. The accu-
racy of this integrated data has been evaluated in Sagar et
al. in terms of precision, recall and F-measure. The analy-
sis of the results displayed precision and recall ranging
from 81%–100% and with an average F-measure of
92.9% for the SCN1A gene [30]. The precompiled reports
in this study are incorporated in the DDEC and provide
the user with a possibility to inspect possible interactions
associated with the genes of interest and associated net-
works of relevant biomedical entities. An additional fea-
ture in DES allows for hypotheses to be generated
between two dictionary entries that are linked to a com-
mon dictionary entry. This tool allows the user to test the
hypotheses generated by retrieving PubMed documents
related to the two dictionary terms linked through the
hypothesis, if no PubMed documents are retrieved the
hypothesis may warrant further exploration. This func-
tioning of the text-mining modules of DDEC is based on
similar concepts as used in Pan et al. [31] and Bajic et al.
[32]. DES has also been employed in the creation of a
module for the ovarian cancer database, DDOC [33].
Batch queries and data download are provided to increase
utility for users. Further, a database dump has been pro-
vided to support integration with other database
resources.
The above outlined process of biocurated data collection
and integration will be repeated twice yearly as an update
process. Updates will incorporate extracting abstracts
from the last update day to current day. This semi-auto-
mated process is more time consuming than current auto-
mated update systems but has the advantage of reducing
redundant information.
Utility and discussion
DDEC provides a comprehensive compilation of informa-
tion obtained from published EC research, comple-
mented with the information from public databases and
information derived from computational analysis. The
information captured in DDEC is centered on genes dif-
ferentially expressed in EC. The information used for
selection of genes to be included in DDEC was curated by
biologists. Only genes that satisfy all conditions listed
below are included in DDEC:
(i) Genes that are differentially expressed in human
EC with experimental proof.
(ii) Differential expression of EC-implicated genes has
not been influenced by anti-cancer therapy.
(iii) Differentially expressed EC-implicated genes have
not been artificially constructed.
Microarray data has been excluded at this stage as the
results obtained using high throughput technologies are
debatable in terms of deciding about a meaningful level of
gene expression and statistical methods used for analysis
and interpretation of data [34,35]. However, as a future
prospect we will expand the database by adding a subset
for raw expression data and analysis of the EC-related
microarray data.
DDEC contains precompiled text-mined and data-mined
reports that allow for easy exploration of information
about associations of EC-implicated genes with other
genes and proteins, metabolites and enzymes, toxins,
chemicals with pharmacological effects, disease concepts,
human anatomy, pathways and pathway reactions. More-
over, DDEC provides for potentially new 'association
hypotheses' generated in the precompiled reports. It also
provides frequency of associations that allows users to
observe rare associations with the genes of interest thatBMC Cancer 2009, 9:219 http://www.biomedcentral.com/1471-2407/9/219
Page 5 of 7
(page number not for citation purposes)
will usually be overlooked in a normal literature search
taking into account the huge volume of data available.
DDEC can be used to answer questions such as:
(1) Is my gene of interest differentially expressed in
EC, i.e. is it an EC-implicated gene as defined here?
(2) Which putative transcription factors regulate the
expression of an EC-implicated gene or sets of these
genes?
(3) Which of the other EC-implicated genes in DDEC
are regulated by the same transcription factor (or fac-
tors) as the gene of interest?
(4) My gene of interest has putative associations with
other biomedical concepts. What are these concepts
and what are the documents from which such associa-
tions are deduced so that I can explore them?
The potential uses and advantages of the database are
described in the documentation section http://
apps.sanbi.ac.za/ddec/ddec.pdf. An example of data anal-
ysis has been included in the documentation and should
help users to understand and utilize different functions
implemented in this database to maximize information
exploration and extraction.
Kaur et al. recently published DDOC, an ovarian cancer
(OC) database housing 379 OC-related genes using the
same database model and query interface [33]. To explore
whether the EC and OC database content characterize
functionally distinct groups of genes, the categories where
probed for statistical over-representation of GO terms
[22,36]. For this analysis we compared the EC and OC
gene lists. We found 123 genes to be common to both
cancer types while 406 genes were unique to EC and 256
genes were unique to OC. Generally, all categories were
characterized by the majority of genes forming part of the
broad terms, apoptosis and cell cycle. However, these cat-
egories were primarily over-represented for the genes
common to both EC and OC (see Table 1). The gene list
unique to EC was found to be enriched in functionally
distinct groups such as 'neuron differentiation and devel-
opment' and 'epidermis development' while the gene list
unique to OC was found to be enriched in functionally
distinct groups such as 'sex differentiation and develop-
ment' and 'embryonic development' (see Table 1).
We further identified which KEGG pathways (see addi-
tional file 1) are enriched for the genes unique to EC,
genes unique to OC and the genes common to EC and OC
[37]. We found the MAPK signaling pathway, ErbB signal-
ing pathway and p53 signaling pathway to be most pro-
nounced pathways for genes common to EC and OC. The
pathways most pronounced for the genes unique to EC
were the MAPK signaling pathway, Wnt signaling path-
way, with androgen and estrogen metabolism being
unique to this group. The MAPK signaling pathway, ErbB
signaling pathway and TGF-beta signaling pathways were
most pronounced for the genes unique to OC.
Above analysis suggests that distinct categories of genes
participating in specific pathways are involved in patho-
genesis of different types of cancers. These cancer specific
categories of genes can be investigated as potential
biomarkers for prognosis and diagnosis of the disease.
In future, we intend to incorporate the effect of current
therapeutic drugs. Additional features that may enhance
Table 1: A comparison of the DDEC and DDOC gene lists.
Gene Ontology terms representing 
functionally distinct groups
Genes unique for Esophageal 
Cancer (EC)
Gene unique for Ovarian Cancer 
(OC)
Genes common to EC and OC
Neuron differentiation and 
development
3.03 0.77 0
Epidermis development 5.91 1.06 1.66
Sex differentiation and development 0.36 1.36 0
Embryonic development 0.76 1.85 0
Regulation of apoptosis 8.09 9.84 13.22
Regulation of cell cycle 11.99 11.31 14.73
* The values tabulated in Table 1 represent the overall enrichment score for the group based on EASE scores of each term members. The higher 
the score the more enriched.
A comparison of Esophageal and Ovarian Cancer genes by characterizing functionally distinct groups based on Gene Ontology terms.BMC Cancer 2009, 9:219 http://www.biomedcentral.com/1471-2407/9/219
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search and retrieval of DDEC information will be added
in due course, as well as incorporation of DDEC into
ICGC, caBIG and LinkOut. DDEC will further be updated
twice a year and will continue to grow in both content and
functionality.
Conclusion
DDEC is an integrated knowledge database aimed at rep-
resenting a gateway to EC-related data. DDEC houses
information associated with 529 hand-curated human
genes implicated in EC and allows the users to easily
access the wealth of EC related data that is typically diffi-
cult to find and not easily amendable to data mining.
Users are also provided with the DES interface that allows
for the easy exploration of information, viewing of poten-
tial associations that are rarely reported and thus difficult
to identify and inspection of potentially new 'association
hypotheses' generated based on the precompiled reports.
We hope that this resource will serve as a useful comple-
ment to the existing public resources and as a good start-
ing point for researchers and physicians interested in EC
genetics.
Availability and requirements
DDEC is freely accessible to academic and non-profit
users at http://apps.sanbi.ac.za/ddec/.
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